UAB has received two grants totaling $3.9 million from the National Institutes of Mental Health, one of the National Institutes of Health, in an effort to better understand schizophrenia and look for new targets for therapies. McCullumsmith is the lead investigator on one of the grants. James Meador-Woodruff, M.D., chair of the Department of Psychiatry and Behavioral Neurobiology, heads the other.
The target of both is glutamate, a major neurotransmitter in the brain. The tools are cutting-edge methodologies, including laser capture micro dissection – a device that can isolate specific cells for detailed analysis – and advanced proteomics techniques that study the function and structure of proteins. The goal is to better understand why there are profound deficits in glutamate signaling and processing in the brains of those with schizophrenia.
“We know that there is something wrong with the handling of glutamate in the brains of people with schizophrenia,” says McCullumsmith. “What we don’t know is just what is wrong. Is there too much glutamate? Too little? Is it in the wrong place at the wrong time? These studies will look for those answers, and hopefully come away with new targets in the brain for medications or other therapies.”
Schizophrenia is an especially troubling condition because it usually begins in young adults between the ages of 18 and 25.
“People who previously had demonstrated relatively normal development and are in the midst of going to college, starting a family or beginning a career suddenly have deterioration in function, including social and occupational skill sets,” says Meador-Woodruff. “They typically are unable to work and have a hard time maintaining interpersonal relationships.”
More financial and community resources go toward the care and treatment of schizophrenia than any other medical illness, says McCullumsmith, and it’s an equal opportunity condition, affecting all socioeconomic segments and populations.
There are medications available to treat what are called the “positive” symptoms of schizophrenia. Positive symptoms are manifestations that a patient has that they should not have, such as hearing voices and suffering from delusions and hallucinations. Those medications, some developed more than 50 years ago, have serious side effects. The older ones can cause movement disorders; the newer versions can spur obesity, heart disease and diabetes.
There are no medications that deal with what are called “negative” symptoms – manifestations a patient should have but does not. These include grasping the concept of non-verbal communication, motivation and even understanding the need for good grooming and hygiene.
Meador-Woodruff says there are also cognitive symptoms such as decline in memory, decision making and problem solving. Again, there are no medications to treat these symptoms.
“We need new treatments for schizophrenia,” says McCullumsmith. “People with schizophrenia are often homeless, unemployed and unemployable.”
In both trials, the researchers will compare brain tissue collected from patients with schizophrenia who donated their brains to brain banks, including the Alabama Brain Collection, a tissue repository managed by Rosalinda Roberts, Ph.D., a professor of psychiatry at UAB.
Comparisons made between schizophrenic brains and normal controls may reveal changes in glutamate signaling, uptake or dispersal. Meador-Woodruff’s main focus will be on glutamate receptors on cells, while McCullumsmith’s project will look at the mechanism by which excess glutamate is removed from the brain.
“Schizophrenia is a disease that likely has many causes,” says Meador-Woodruff. “There is strong evidence that glutamate plays an important role in the development of the disease. Hopefully, these studies will help define that role and lead us to a better understanding of how to treat schizophrenia.”About UAB
EDITOR’S NOTE: The University of Alabama at Birmingham (UAB) is a separate, independent institution from the University of Alabama, which is located in Tuscaloosa. Please use University of Alabama at Birmingham on first reference and UAB on second reference.
VIDEO: www.youtube.com/uabnews TEXT: www.uab.edu/news TWEETS: www.twitter.com/uabnews
Bob Shepard | Newswise Science News
Study relating to materials testing Detecting damages in non-magnetic steel through magnetism
23.07.2018 | Technische Universität Kaiserslautern
Innovative genetic tests for children with developmental disorders and epilepsy
11.07.2018 | Christian-Albrechts-Universität zu Kiel
Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.
When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...
Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.
Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....
Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.
Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...
Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur
What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...
The quality of materials often depends on the manufacturing process. In casting and welding, for example, the rate at which melts solidify and the resulting microstructure of the alloy is important. With metallic foams as well, it depends on exactly how the foaming process takes place. To understand these processes fully requires fast sensing capability. The fastest 3D tomographic images to date have now been achieved at the BESSY II X-ray source operated by the Helmholtz-Zentrum Berlin.
Dr. Francisco Garcia-Moreno and his team have designed a turntable that rotates ultra-stably about its axis at a constant rotational speed. This really depends...
08.08.2018 | Event News
27.07.2018 | Event News
25.07.2018 | Event News
14.08.2018 | Information Technology
14.08.2018 | Life Sciences
14.08.2018 | Life Sciences